Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays
Authors
Keywords
Angiogenesis, Insulin secretion, Wnt signaling cascade, Library screening, Drug research and development, Drug discovery, Small molecules, MAPK signaling cascades
Journal
PLoS One
Volume 10, Issue 7, Pages e0130796
Publisher
Public Library of Science (PLoS)
Online
2015-07-16
DOI
10.1371/journal.pone.0130796
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blocking Lipid Synthesis Overcomes Tumor Regrowth and Metastasis after Antiangiogenic Therapy Withdrawal
- (2014) Nor Eddine Sounni et al. Cell Metabolism
- Open Innovation Drug Discovery (OIDD): A Potential Path to Novel Therapeutic Chemical Space
- (2014) Maria Alvim-Gaston et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells
- (2014) Lesley A. Mathews Griner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- What general conclusions can we draw from kinase profiling data sets?
- (2013) Jeffrey J. Sutherland et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Mechanisms of resistance to anti-angiogenesis therapies
- (2013) Sandy Giuliano et al. BIOCHIMIE
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
- (2013) Amrita Basu et al. CELL
- Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs
- (2013) Min Shen et al. PLoS One
- Systems Pharmacology of Adverse Event Mitigation by Drug Combinations
- (2013) S. Zhao et al. Science Translational Medicine
- The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas
- (2012) F Seguin et al. BRITISH JOURNAL OF CANCER
- Differential WNT Activity in Colorectal Cancer Confers Limited Tumorigenic Potential and Is Regulated by MAPK Signaling
- (2012) D. Horst et al. CANCER RESEARCH
- Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy
- (2012) Jonathan A. Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects
- (2012) Antonio Garcia-Gomez et al. PLoS One
- Phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis
- (2012) M. M. P. Schulz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role
- (2012) Krista S. Crider et al. Advances in Nutrition
- The food colorant erythrosine is a promiscuous protein–protein interaction inhibitor
- (2011) Lakshmi Ganesan et al. BIOCHEMICAL PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Glucocorticoids and Tumor Necrosis Factor α Increase Oxidative Stress and Suppress Wnt Protein Signaling in Osteoblasts
- (2011) Maria Almeida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: A population-based cohort study
- (2011) Seo Young Kim et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Optimization of Propafenone Analogues as Antimalarial Leads
- (2011) David J. Lowes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations
- (2011) Jeeyun Lee et al. JNCI-Journal of the National Cancer Institute
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets
- (2011) J. Yuan et al. SCIENCE
- The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
- (2011) R. Huang et al. Science Translational Medicine
- Wnt signaling regulates mitochondrial physiology and insulin sensitivity
- (2010) J. C. Yoon et al. GENES & DEVELOPMENT
- Functional interactions between the LRP6 WNT co-receptor and folate supplementation
- (2010) Jason D. Gray et al. HUMAN MOLECULAR GENETICS
- Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
- (2010) F. L'Episcopo et al. NEUROBIOLOGY OF DISEASE
- Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
- (2010) E F Dunn et al. ONCOGENE
- De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
- (2009) T Mashima et al. BRITISH JOURNAL OF CANCER
- Deguelin Inhibits Growth of Breast Cancer Cells by Modulating the Expression of Key Members of the Wnt Signaling Pathway
- (2009) G. Murillo et al. Cancer Prevention Research
- Folate rescues lithium-, homocysteine- and Wnt3A-induced vertebrate cardiac anomalies
- (2009) M. Han et al. Disease Models & Mechanisms
- Associations between methotrexate treatment and methylenetetrahydrofolate reductase gene polymorphisms with incident fractures in Japanese female rheumatoid arthritis patients
- (2009) Wako Urano et al. JOURNAL OF BONE AND MINERAL METABOLISM
- DNA methylation, an epigenetic mechanism connecting folate to healthy embryonic development and aging
- (2009) Kyong-chol Kim et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)
- (2009) A Arlt et al. ONCOGENE
- A Lentivirus-Mediated Genetic Screen Identifies Dihydrofolate Reductase (DHFR) as a Modulator of β-Catenin/GSK3 Signaling
- (2009) Richard A. Klinghoffer et al. PLoS One
- Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2
- (2008) T. Lee et al. MOLECULAR PHARMACOLOGY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives
- (2008) Marie-Laure Volvert et al. BMC Pharmacology & Toxicology
- Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines
- (2007) J CROTT et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now